Navigation Links
Nationwide Health Properties, Inc. Announces the Redemption of All Outstanding Shares of 7.75% Series B Cumulative Convertible Preferred Stock
Date:12/18/2009

NEWPORT BEACH, Calif., Dec. 18 /PRNewswire-FirstCall/ -- Nationwide Health Properties, Inc. (NYSE: NHP) announced today that it has given notice that it is redeeming all of its outstanding shares of 7.75% Series B Cumulative Convertible Preferred Stock ("Series B Preferred Stock") (NHP-PB - CUSIP No. 638620302) on January 18, 2010 at a redemption price per share of $103.875 plus an amount equal to accumulated and unpaid dividends thereon to the redemption date ($0.3875), for a total redemption price of $104.2625 per share. The redemption price is payable only in cash.

As a result of the redemption, the Series B Preferred Stock will be convertible into shares of NHP common stock until the close of business on January 14, 2010. Each share of Series B Preferred Stock may be converted into 4.515 shares of NHP common stock through BNY Mellon Shareowner Services at the address below.

NHP previously authorized the payment of a quarterly dividend on the Series B Preferred Stock, in the amount of $1.9375 per share, payable on December 31, 2009, to holders of record as of December 15, 2009. Holders of shares of Series B Preferred Stock at the close of business on the record date will be entitled to receive the dividend payment on such shares on the payment date notwithstanding the conversion of such shares following the record date.

If not earlier converted, the redemption of shares and payment will be made in accordance with the terms specified in the redemption notices sent to holders. BNY Mellon Shareowner Services is acting as redemption agent, and may be contacted at (201) 680-4364.


    By Mail or Overnight to:

    BNY Mellon Shareowner Services
    480 Washington Boulevard, 27th Floor
    Jersey City, NJ 07310
    Attention:  Corporate Actions Department
    Phone:  (800) 777-3674

Nationwide Health Properties, Inc. is a real estate investment trust (REIT) that invests primarily in healthcare real estate in the United States. As of September 30, 2009, the Company's portfolio of properties, including mortgage loans and properties owned by unconsolidated joint ventures, totaled 579 properties among the following segments: 279 senior housing facilities, 200 skilled nursing facilities, 82 medical office buildings, 11 continuing care retirement communities and 7 specialty hospitals. For more information on Nationwide Health Properties, Inc., visit our website at http://www.nhp-reit.com.


    CONTACT:
    Abdo H. Khoury
    Chief Financial and Portfolio Officer
    Nationwide Health Properties, Inc.
    (949) 718-4400

SOURCE Nationwide Health Properties, Inc.


'/>"/>
SOURCE Nationwide Health Properties, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Flu Vaccinations Begin on September 29 Maxim Health Systems to Provide 24,000 Flu Shot Clinics Nationwide
2. Joint NJ/NY Rally for Addiction Recovery to Be Hub of Events Nationwide
3. Photo: Tanger Outlet Center Shoppers Nationwide can Choose Pink to Fight Breast Cancer
4. Joint Juice Launches New Ready-to-Drink Glucosamine & Vitamin-Enhanced Dietary Supplement Water Nationwide
5. Activate America(R) Brings Together YMCAs Nationwide to Promote Small Steps Toward a Healthier Lifestyle During America on the Move Week With the YMCA, September 22-29, 2007
6. NIH/NCI renews and extends nationwide license for Genomatix software and databases
7. 100 Black Men of America, Inc. and American Red Cross Sign National Agreement to Increase Diverse Outreach Nationwide
8. New Website Launches Healthy Vending in Schools Nationwide to Help Combat Childhood Obesity
9. First Nationwide Class Action Filed on Behalf of Consumers Who Purchased Topps E. Coli Contaminated Ground Beef
10. American Cancer Society awards research grants to 109 investigators at 77 institutions nationwide
11. Nationwide independent Taser study results suggest devices are safe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)... ... 01, 2017 , ... Financial Recovery Group, Inc. (FRG), is proud to announce ... Nashville, Tenn. The company also is offering a special discount for those who attend ... year, brings together the brightest minds in the healthcare industry to share information on ...
(Date:3/1/2017)... ... March 01, 2017 , ... Look for a new collection of ... and Drift Roses. Star Roses and Plants is launching their new Bushel and ... Bushel and Berry Collection makes growing fresh fruit simple with a variety of easy-to-grow, ...
(Date:3/1/2017)... , ... March 01, 2017 , ... On January 27, ... Firm, filed a civil sex abuse lawsuit in the Circuit Court of Kanawha County, ... have only been identified by their initials. See L.B. and T.B. v. Seventh-Day Adventist ...
(Date:3/1/2017)... , ... March 01, 2017 , ... Award-winning medical group ... 25 medical mission trips in underdeveloped nations, averaging more than one trip per year ... article on the website features the details of his charitable work. Char ...
(Date:3/1/2017)... ... 2017 , ... NYC based Integrated practice Living Well Medical, a long time ... of Orthopaedic Surgeon Dr. Donald E. Heitman. Dr. Heitman is a native ... Bachelor of Science degree in biology. He then obtained his medical degree from New ...
Breaking Medicine News(10 mins):
(Date:3/1/2017)... Sun Chlorella Corp ., the California -based ... Non-GMO Project Verification and the launch of individual serving packets ... for the Natural Products Expo West trade show, March 10-12 ... Chlorella Corp. has announced the Non-GMO Project Verification logo is ... Sun Chlorella tablets, 250mg and 500mg (20/100-day supplies) ...
(Date:3/1/2017)... March 1, 2017  Integrated Modular Design ... design and implementation of pre-fabricated healthcare products ... room headwalls, seeks to lead the construction ... solutions. Fueled by their leading-edge ... of reducing construction timelines and project risk, ...
(Date:3/1/2017)... , March 1, 2017  Global biotherapeutics leader ... the largest ever Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) trial, ... T reatment with H izentra ® ).  ... the efficacy, safety and tolerability of two different doses ... (Immune Globulin Subcutaneous [Human]), compared with placebo, in the ...
Breaking Medicine Technology: